Compare OneStudyTeam vs. ArcheMedX Ready

We create innovative solutions that enhance and strengthen the clinical trial ecosystem. Our platform for Enrollment Performance Management is favored by research sites and relied upon by sponsors. It is utilized by 2,000 research sites in 26 countries and is endorsed by half of the world's top-20 biopharma companies. This enables sites to reduce time spent on repetitive and manual activities, facilitating a smoother patient progression. By minimizing redundant efforts, there are fewer logs, phone calls, and emails required from both sites and sponsors. Sponsors can proactively improve enrollment with immediate access to advanced pre-screening and enrollment metrics. Our remarkably straightforward patient recruitment and enrollment solution is trusted by over 1,800 sites worldwide. Gain access to impactful recruitment and enrollment insights, ensuring clinical trials are conducted faster and with greater predictability. By eliminating unnecessary tasks, sites can refocus their efforts on what truly matters: providing assistance to patients. Effortlessly manage recruitment across all trials, sponsors, or CROs with the ability to input information once and have it directed where it is needed most. This innovative approach not only streamlines the process but also enhances collaboration among all stakeholders involved in clinical trials.

Ready by ArcheMedX for Pharma and Biotech Trusts to better equip their trial team, improve decision-making, and reduce study delays By understanding which sites and teams are best equipped to conduct the study, you can avoid the most common causes of study delays. Reduce the time and cost of resolving problems, especially early in a trial. You can be confident that the sites you choose truly understand your patient eligibility requirements. You'll feel more confident that they will be better equipped to help you enroll eligible patients faster, meet enrollment targets, and avoid screen failures. You can be confident that the trial team is fully conversant with the protocol, down to the individual and study objectives. You can predict where there are risks so that you can avoid them and have fewer deviations overall.